News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
782,743 Results
Type
Article (56211)
Company Profile (375)
Press Release (726144)
Multimedia
Podcasts (148)
Webinars (23)
Section
Business (219441)
Career Advice (2912)
Deals (38062)
Drug Delivery (136)
Drug Development (87518)
Employer Resources (187)
FDA (17573)
Job Trends (16284)
News (373733)
Policy (36567)
Tag
Academia (2921)
Academic (1)
Accelerated approval (25)
Adcomms (35)
Allergies (135)
Alliances (53959)
ALS (170)
Alzheimer's disease (1738)
Antibody-drug conjugate (ADC) (301)
Approvals (17695)
Artificial intelligence (520)
Autoimmune disease (127)
Automation (33)
Bankruptcy (392)
Best Places to Work (12240)
BIOSECURE Act (22)
Biosimilars (189)
Biotechnology (221)
Bladder cancer (152)
Brain cancer (58)
Breast cancer (615)
Cancer (4646)
Cardiovascular disease (404)
Career advice (2460)
Career pathing (39)
CAR-T (285)
CDC (57)
Celiac Disease (1)
Cell therapy (747)
Cervical cancer (35)
Clinical research (73791)
Collaboration (1575)
Company closure (5)
Compensation (1071)
Complete response letters (64)
COVID-19 (2925)
CRISPR (93)
C-suite (743)
Cystic fibrosis (143)
Data (5819)
Decentralized trials (2)
Denatured (43)
Depression (130)
Diabetes (487)
Diagnostics (6984)
Digital health (40)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (236)
Drug pricing (203)
Drug shortages (35)
Duchenne muscular dystrophy (225)
Earnings (93105)
Editorial (60)
Employer branding (23)
Employer resources (164)
Events (125323)
Executive appointments (1007)
FDA (20405)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1398)
Gene editing (199)
Generative AI (46)
Gene therapy (600)
GLP-1 (1062)
Government (5179)
Grass and pollen (8)
Guidances (379)
Healthcare (20217)
HIV (53)
Huntington's disease (43)
IgA nephropathy (80)
Immunology and inflammation (272)
Immuno-oncology (41)
Indications (77)
Infectious disease (3189)
Inflammatory bowel disease (194)
Inflation Reduction Act (14)
Influenza (106)
Intellectual property (215)
Interviews (562)
IPO (17323)
IRA (57)
Job creations (4413)
Job search strategy (2013)
Kidney cancer (17)
Labor market (80)
Layoffs (628)
Leadership (38)
Legal (9099)
Liver cancer (95)
Longevity (13)
Lung cancer (643)
Lymphoma (358)
Machine learning (39)
Management (64)
Manufacturing (721)
MASH (166)
Medical device (14387)
Medtech (14426)
Mergers & acquisitions (21710)
Metabolic disorders (1273)
Multiple sclerosis (151)
NASH (23)
Neurodegenerative disease (314)
Neuropsychiatric disorders (84)
Neuroscience (2915)
NextGen: Class of 2025 (7194)
Non-profit (4918)
Now hiring (60)
Obesity (612)
Opinion (314)
Ovarian cancer (152)
Pain (192)
Pancreatic cancer (199)
Parkinson's disease (269)
Partnered (31)
Patents (464)
Patient recruitment (407)
Peanut (59)
People (64033)
Pharmaceutical (102)
Pharmacy benefit managers (30)
Phase I (22917)
Phase II (32293)
Phase III (24236)
Pipeline (3909)
Policy (312)
Postmarket research (2991)
Preclinical (9834)
Press Release (71)
Prostate cancer (226)
Psychedelics (53)
Radiopharmaceuticals (279)
Rare diseases (796)
Real estate (6690)
Recruiting (76)
Regulatory (26433)
Reports (52)
Research institute (2633)
Resumes & cover letters (458)
Rett syndrome (24)
RNA editing (14)
RSV (81)
Schizophrenia (147)
Series A (233)
Series B (174)
Service/supplier (16)
Sickle cell disease (100)
Special edition (25)
Spinal muscular atrophy (167)
Sponsored (43)
Startups (3985)
State (2)
Stomach cancer (19)
Supply chain (105)
Tariffs (96)
The Weekly (103)
Vaccines (1070)
Venture capital (78)
Weight loss (424)
Women's health (75)
Worklife (20)
Date
Today (129)
Last 7 days (559)
Last 30 days (2542)
Last 365 days (31893)
2025 (31264)
2024 (36944)
2023 (41842)
2022 (53090)
2021 (57789)
2020 (56649)
2019 (49960)
2018 (37848)
2017 (34947)
2016 (34973)
2015 (40948)
2014 (35077)
2013 (30467)
2012 (32478)
2011 (33060)
2010 (31280)
Location
Africa (976)
Alabama (80)
Alaska (7)
Arizona (304)
Arkansas (14)
Asia (45702)
Australia (7990)
California (10615)
Canada (3137)
China (1043)
Colorado (442)
Connecticut (457)
Delaware (317)
Europe (100378)
Florida (1578)
Georgia (339)
Hawaii (2)
Idaho (65)
Illinois (842)
India (59)
Indiana (509)
Iowa (21)
Japan (378)
Kansas (125)
Kentucky (38)
Louisiana (24)
Maine (70)
Maryland (1356)
Massachusetts (7745)
Michigan (311)
Minnesota (614)
Mississippi (6)
Missouri (130)
Montana (32)
Nebraska (26)
Nevada (117)
New Hampshire (78)
New Jersey (2874)
New Mexico (31)
New York (2835)
North Carolina (1462)
North Dakota (9)
Northern California (5073)
Ohio (312)
Oklahoma (21)
Oregon (45)
Pennsylvania (2173)
Puerto Rico (20)
Rhode Island (47)
South America (1349)
South Carolina (59)
South Dakota (1)
Southern California (4102)
Tennessee (167)
Texas (1649)
United States (38306)
Utah (318)
Vermont (1)
Virginia (260)
Washington D.C. (83)
Washington State (888)
West Virginia (4)
Wisconsin (98)
Wyoming (2)
782,743 Results for "aurinia formerly known as isotechnika pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
FDA’s Tidmarsh Singles Out Aurinia’s Drug in LinkedIn Post About Surrogate Endpoints
Without naming Aurinia Pharmaceuticals, the CDER director in a now-deleted LinkedIn post claimed that for lupus nephritis, companies have not conducted post-approval studies “to demonstrate a benefit on hard clinical endpoints.”
September 30, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Five Assets Given Away by Big Pharma That Ultimately Got Bought for Billions
Drug candidates don’t usually move among Big Pharma, but these five biotechs helped facilitate such hand-offs, scooping up assets from one pharma on the cheap before being bought out for billions by another.
November 19, 2025
·
9 min read
·
Tristan Manalac
Japan
Japanese Pharmas Looking Beyond Borders for M&A to US, EU
Long a quieter, locally focused industry, Japanese pharma giants are increasingly looking to the rest of the world for deals.
December 10, 2025
·
7 min read
·
Dan Samorodnitsky
Press Releases
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress
November 5, 2025
·
9 min read
Press Releases
Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025
November 4, 2025
·
1 min read
Press Releases
Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025
July 31, 2025
·
9 min read
Insights
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year of transformation and renewed momentum for life sciences.
November 12, 2025
·
5 min read
·
Jennifer Smith-Parker
Press Releases
Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®
November 13, 2025
·
4 min read
Press Releases
Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025
October 15, 2025
·
2 min read
Press Releases
Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025
July 22, 2025
·
1 min read
1 of 78,275
Next